U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C22H22FN5O7
Molecular Weight 487.4378
Optical Activity UNSPECIFIED
Defined Stereocenters 4 / 4
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of ZOLIFLODACIN

SMILES

[H][C@]12[C@H](C)O[C@H](C)CN1C3=C(CC24C(=O)NC(=O)NC4=O)C=C5C(=NOC5=C3F)N6[C@@H](C)COC6=O

InChI

InChIKey=ZSWMIFNWDQEXDT-ZESJGQACSA-N
InChI=1S/C22H22FN5O7/c1-8-7-33-21(32)28(8)17-12-4-11-5-22(18(29)24-20(31)25-19(22)30)16-10(3)34-9(2)6-27(16)14(11)13(23)15(12)35-26-17/h4,8-10,16H,5-7H2,1-3H3,(H2,24,25,29,30,31)/t8-,9+,10-,16+/m0/s1

HIDE SMILES / InChI
Zoliflodacin (also known as AZD0914 or ETX0914) is a spiropyrimidinetrione with activity against bacterial type II topoisomerases that inhibits DNA biosynthesis and results in accumulation of double-strand cleavages in bacteria. This drug is being a DNA gyrase inhibitor, targeting Neisseria gonorrhoeae and is currently in phase II clinical trial in adults to treat uncomplicated urogenital gonorrhea.

Approval Year

PubMed

PubMed

TitleDatePubMed
In vitro activity of AZD0914, a novel DNA gyrase inhibitor, against Chlamydia trachomatis and Chlamydia pneumoniae.
2014 Dec
High in vitro activity of the novel spiropyrimidinetrione AZD0914, a DNA gyrase inhibitor, against multidrug-resistant Neisseria gonorrhoeae isolates suggests a new effective option for oral treatment of gonorrhea.
2014 Sep
Single-Dose Zoliflodacin (ETX0914) for Treatment of Urogenital Gonorrhea.
2018 Nov 8
Single-Dose Pharmacokinetics, Excretion, and Metabolism of Zoliflodacin, a Novel Spiropyrimidinetrione Antibiotic, in Healthy Volunteers.
2019 Jan

Sample Use Guides

AZD0914 (ZOLIFLODACIN) is an antimicrobial amorphous nonsterile powder. Group 1 receive 2000 mg; Group 2 receive 3000 mg.
Route of Administration: Oral
Name Type Language
ZOLIFLODACIN
INN   USAN   WHO-DD  
USAN   INN  
Official Name English
AZD0914
Code English
ETX-0914
Code English
AZD-0914
Code English
(2R,4S,4AS)-11-FLUORO-2,4-DIMETHYL-8-((4S)-4-METHYL-2-OXO-1,3-OXAZOLIDIN-3-YL)-1,2,4,4A-TETRAHYDRO-2'H,6H-SPIRO((1,2)-OXAZOLO(4,5-G)(1,4)OXAZINO(4,3-A)QUINOLINE-5,5'-PYRIMIDINE)-2',4',6'(1'H,3'H)-TRIONE
Systematic Name English
zoliflodacin [INN]
Common Name English
ZOLIFLODACIN [USAN]
Common Name English
SPIRO(ISOXAZOLO(4,5-G)(1,4)OXAZINO(4,3-A)QUINOLINE-5(6H),5'(2'H)-PYRIMIDINE)-2',4',6'(1'H,3'H)-TRIONE, 11-FLUORO-1,2,4,4A-TETRAHYDRO-2,4-DIMETHYL-8-((4S)-4-METHYL-2-OXO-3-OXAZOLIDINYL)-, (2R,4S,4AS)-
Systematic Name English
ETX0914
Code English
Zoliflodacin [WHO-DD]
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C258
Created by admin on Sat Dec 16 09:42:50 GMT 2023 , Edited by admin on Sat Dec 16 09:42:50 GMT 2023
Code System Code Type Description
SMS_ID
300000009721
Created by admin on Sat Dec 16 09:42:50 GMT 2023 , Edited by admin on Sat Dec 16 09:42:50 GMT 2023
PRIMARY
EPA CompTox
DTXSID101028418
Created by admin on Sat Dec 16 09:42:50 GMT 2023 , Edited by admin on Sat Dec 16 09:42:50 GMT 2023
PRIMARY
CAS
1620458-09-4
Created by admin on Sat Dec 16 09:42:50 GMT 2023 , Edited by admin on Sat Dec 16 09:42:50 GMT 2023
PRIMARY
DRUG BANK
DB12817
Created by admin on Sat Dec 16 09:42:50 GMT 2023 , Edited by admin on Sat Dec 16 09:42:50 GMT 2023
PRIMARY
FDA UNII
FWL2263R77
Created by admin on Sat Dec 16 09:42:50 GMT 2023 , Edited by admin on Sat Dec 16 09:42:50 GMT 2023
PRIMARY
PUBCHEM
76685216
Created by admin on Sat Dec 16 09:42:50 GMT 2023 , Edited by admin on Sat Dec 16 09:42:50 GMT 2023
PRIMARY
INN
10285
Created by admin on Sat Dec 16 09:42:50 GMT 2023 , Edited by admin on Sat Dec 16 09:42:50 GMT 2023
PRIMARY
WIKIPEDIA
Zoliflodacin
Created by admin on Sat Dec 16 09:42:50 GMT 2023 , Edited by admin on Sat Dec 16 09:42:50 GMT 2023
PRIMARY
ChEMBL
CHEMBL3544978
Created by admin on Sat Dec 16 09:42:50 GMT 2023 , Edited by admin on Sat Dec 16 09:42:50 GMT 2023
PRIMARY
USAN
CD-63
Created by admin on Sat Dec 16 09:42:50 GMT 2023 , Edited by admin on Sat Dec 16 09:42:50 GMT 2023
PRIMARY
NCI_THESAURUS
C152962
Created by admin on Sat Dec 16 09:42:50 GMT 2023 , Edited by admin on Sat Dec 16 09:42:50 GMT 2023
PRIMARY